Innovative therapeutics

Funding and
Support

Funding and Support

Grants and Charitable Contributions

With a growing list of marketed products and a fully-integrated multinational organization in place, BioMarin provides first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with serious and life-threatening rare genetic diseases. BioMarin is committed to patients, families, and physicians in providing rapid access to treatments, disease education, and support services.

BioMarin supports programs and activities that foster excellence in patient care and provide valuable scientific, medical, and educational information to the medical and scientific communities as well as patient advocacy organizations.

The company is also strongly committed to clinicians and the Independent Research they conduct to advance knowledge about rare diseases and BioMarin’s products.

Please select the support type that interests you:

Grants or Charitable Contributions
US/Canada

  • Educational Grants
    • CME accredited programs
    • Non-CME accredited programs
  • Research Grants (animal models and lab work)
  • Charitable Donations
  • Sponsorships

EUMEA

  • Charitable Donation
  • CME Funding for HCP Grant
  • Patient Organisation Grant
  • Research Grant (animal models and lab work)
  • General Grant
Global Independent Research

    Material and/or funding may be provided for independent research in the areas of rare diseases and genetic disorders. The Independent Research Program covers clinical research, whether or not a drug product or candidate is involved.

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI) PKU, LEMS

Products

Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information

Top